ALNY reports better-than-expected fourth-quarter results as both earnings and revenues beat estimates driven by higher product sales.
Vous n'êtes pas connecté
Halozyme reports better-than-expected fourth-quarter 2024 results. The company maintains revenue guidance for 2025.
ALNY reports better-than-expected fourth-quarter results as both earnings and revenues beat estimates driven by higher product sales.
Amicus' fourth-quarter 2024 earnings miss estimates while revenues beat the same.
DVN reports better-than-expected fourth-quarter earnings and revenues. The company continues to enjoy benefits from its multi-basin assets.
AWK reports better-than-expected fourth-quarter earnings and revenues. The company continues to expand operation through acquisitions and organic...
Baxter reports better-than-expected fourth-quarter results. However, the company's gross and operating margins contract. Shares rise in pre-market.
MRNA's earnings and revenues surpass estimates in the fourth quarter of 2024. The company reiterates 2025 total revenue guidance.
CDNS reports better-than-expected fourth-quarter results on solid demand trends. Revenues for 2025 are expected to be in the range of $5.14-$5.22...
IONS reports better-than-expected top and bottom-line numbers for the fourth quarter.
Incyte reports mixed fourth-quarter 2024 results as earnings miss estimates while revenues beat the same. Jakafi and Opzelura drive year-over-year...
MGA reports better-than-expected fourth-quarter results and expects 2025 revenues in the band of $38.6-$40.2 billion compared with $42.8 billion...